SCHEMBL8120022

SCHEMBL8120022

CCCCCC(CC(=O)Nc1cc(C(N)=O)ccc1C(C)(C)C)c1ccc(C(=O)CCC)cc1OC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.39
KMT2A Q03164 1/20 0.39
MAPK1 P28482 1/20 0.36
THRA P10827 2/20 0.35
THRB P10828 2/20 0.35
PDE4D Q08499 8/20 0.35
GAA P10253 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
PDE4A P27815 6/20 0.34
PDE4B Q07343 6/20 0.34
PDE4C Q08493 6/20 0.34
LMNA P02545 1/20 0.34
HDAC3 O15379 1/20 0.33
HDAC4 P56524 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC7 Q8WUI4 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC10 Q969S8 1/20 0.33
HDAC11 Q96DB2 1/20 0.33
HDAC8 Q9BY41 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8130312 0.94 KMT2A (0.39) L3MBTL1KMT2AMAPK1THRATHRB
SCHEMBL8130835 0.94 KMT2A (0.41) L3MBTL1KMT2AMAPK1PDE4DPDE4A
SCHEMBL8121793 0.92 ERAP2 (0.39) L3MBTL1KMT2ATHRATHRBPDE4D
SCHEMBL8134962 0.92 THRA (0.38) L3MBTL1THRATHRBGAATDP1
SCHEMBL8128937 0.92 KMT2A (0.40) L3MBTL1KMT2AMAPK1PDE4DPDE4A
SCHEMBL8129705 0.92 L3MBTL1 (0.40) L3MBTL1KMT2AMAPK1PDE4DGAA
SCHEMBL8120272 0.90 KMT2A (0.39) L3MBTL1KMT2AMAPK1PDE4DGAA
SCHEMBL8205258 0.90 KMT2A (0.39) L3MBTL1KMT2AMAPK1PDE4DPDE4A
SCHEMBL8142215 0.90 KMT2A (0.39) L3MBTL1KMT2AMAPK1PDE4DPDE4A
SCHEMBL8129666 0.90 L3MBTL1 (0.42) L3MBTL1KMT2AMAPK1GAATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0763524-B1 Urea and amide derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prophylactic use SANKYO CO (JP) 2000-08-23 EP claimed
US-5880147-A Amide derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prohylactic use SANKYO COMPANY, LIMITED (JP) 1999-03-09 US claimed
EP-0763524-A1 Urea and amide derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prophylactic use SANKYO COMPANY LIMITED (JP) 1997-03-19 EP claimed
EP-0763524-B1 Urea and amide derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prophylactic use SANKYO CO (JP) 2000-08-23 EP disclosed
US-6040339-A TREATMENT AND PROPHYLAXIS OF HYPERCHOLESTEREMIA OR ARTERIOSCLEROSIS IN A MAMMAL SANKYO COMPANY, LIMITED (JP) 2000-03-21 US disclosed
US-5880147-A Amide derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prohylactic use SANKYO COMPANY, LIMITED (JP) 1999-03-09 US disclosed
EP-0763524-A1 Urea and amide derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prophylactic use SANKYO COMPANY LIMITED (JP) 1997-03-19 EP disclosed